Participated in Corner Therapeutics' $54M Series A led by Ziff Capital Partners.
Corner Therapeutics is an immunotherapy company unlocking lifelong protection from cancer and infectious diseases using its novel dendritic cell stimuli platforms
Corner Therapeutics is an immunotherapy company unlocking lifelong protection from cancer and infectious diseases using its novel dendritic cell stimuli platforms.